Reducing Non-Core Trial Procedures Could Save Billions: Tufts Researcher

Clinical Trials Advisor
A A
Drugmakers are paying anywhere from $3 billion to $5 billion annually for clinical trial procedures that may not be necessary, a new study concludes.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00